3D modeling of effects of increased oxygenation and activity concentration in tumors treated with radionuclides and antiangiogenic drugs

Medical Physics

Volumn 38, Issue 8, 2011, Pages 4888-4893

  Lagerlöf, Jakob H ^a   Kindblom, Jon ^b   Bernhardt, Peter ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

angiogenesis; dosimetry; modeling; radionuclide therapy; tumor control probability

Indexed keywords

3D MODELING; BLOOD VESSELS; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DOSIMETRY; MODELS; OXYGEN; OXYGENATION; PROBABILITY DISTRIBUTIONS; RADIOISOTOPES; TRANSMISSION CONTROL PROTOCOL;

ACTIVITY CONCENTRATION; ANGIOGENESIS; ANTIANGIOGENIC AGENT; OXYGEN DISTRIBUTION; OXYGEN ENHANCEMENT; RADIONUCLIDE THERAPY; THERAPEUTIC EFFECTS; TUMOR CONTROL PROBABILITY;

TUMORS;

EID: 79961054453     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3615164     Document Type: Article

References (23)

1. R. K. Jain, E. di Tomaso, D. G. Duda, J. S. Loeffler, A. G. Sorensen, and T. T. Batchelor, Angiogenesis in brain tumours., Nat. Rev. Neurosci. 8 (8), 610-622 (2007). 10.1038/nrn2175 (Pubitemid 47093931)
2. C. G. Lee, M. Heijn, E. di Tomaso, G. Griffon-Etienne, M. Ancukiewicz, C. Koike, K. R. Park, N. Ferrara, R. K. Jain, H. D. Suit, and Y. Boucher, Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions., Cancer Res. 60 (19), 5565-5570 (2000).
3. V. P. Antipas, G. S. Stamatakos, N. K. Uzunoglu, D. D. Dionysiou, and R. G. Dale, A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration., Phys. Med. Biol. 49 (8), 1485-1504 (2004). 10.1088/0031-9155/49/8/008 (Pubitemid 38578499)
4. J. Z. Wang, X. A. Li, and N. A. Mayr, Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data., Br. J. Radiol. 79 (947), 905-911 (2006). 10.1259/bjr/18700614 (Pubitemid 44782007)
5. A. E. Nahum, B. Movsas, E. M. Horwitz, C. C. Stobbe, and J. D. Chapman, Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio., Int. J. Radiat. Oncol., Biol., Phys. 57 (2), 391-401 (2003). 10.1016/S0360-3016(03)00534-0 (Pubitemid 37040935)
6. G. S. Stamatakos, V. P. Antipas, N. K. Uzunoglu, and R. G. Dale, A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density., Br. J. Radiol. 79 (941), 389-400 (2006). 10.1259/bjr/30604050 (Pubitemid 43676342)
7. O. Ndubuizu and J. C. LaManna, Brain tissue oxygen concentration measurements., Antioxid. Redox Signal 9 (8), 1207-1219 (2007). 10.1089/ars.2007.1634 (Pubitemid 47080830)
8. R. K. Jain, R. T. Tong and L. L. Munn, Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model., Cancer Res. 67 (6), 2729-2735 (2007). 10.1158/0008-5472.CAN-06-4102 (Pubitemid 46548961)
9. T. Kayama, T. Yoshimoto, S. Fujimoto, and Y. Sakurai, Intratumoral oxygen pressure in malignant brain tumor., J. Neurosurg. 74 (1), 55-59 (1991). 10.3171/jns.1991.74.1.0055
10. J. P. Kirkpatrick, L. I. Cardenas-Navia, and M. W. Dewhirst, Predicting the effect of temporal variations in PO2 on tumor radiosensitivity., Int. J. Radiat. Oncol., Biol., Phys. 59 (3), 822-833 (2004). 10.1016/j.ijrobp.2004.02. 015 (Pubitemid 38748748)
11. P. Bernhardt, H. Ahlman, and E. Forssell-Aronsson, Model of metastatic growth valuable for radionuclide therapy., Med. Phys. 30 (12), 3227-3232 (2003). 10.1118/1.1628851 (Pubitemid 37553763)
12. P. Bernhardt, H. Ahlman, and E. Forssell-Aronsson, Modelling of metastatic cure after radionuclide therapy: influence of tumor distribution, cross-irradiation, and variable activity concentration., Med. Phys. 31 (9), 2628-2635 (2004). 10.1118/1.1786531 (Pubitemid 39287880)
13. H. Uusijarvi, N. Chouin, P. Bernhardt, L. Ferrer, M. Bardies, and E. Forssell-Aronsson, Comparison of electron dose-point kernels in water generated by the Monte Carlo codes, PENELOPE, GEANT4, MCNPX, and ETRAN., Cancer Biother. Radiopharm. 24 (4), 461-467 (2009). 10.1089/cbr.2008.0573
14. S. Y. F. Chu, L. P. Ekstrm, and R. B. Firestone, WWW Table of Radioactive Isotopes, (Lawrence Berkeley National Laboratory, 1999).
15. F. H. Attix, Introduction to Radiological Physics and Radiation Dosimetry (Wiley, New York, 1986).
16. M. J. Berger, J. S. Coursey, M. A. Zucker, and J. Chang, ESTAR, PSTAR, and ASTAR: Computer Programs for Calculating Stopping-Power and Range Tables for Electrons, Protons, and Helium Ions (version 1.2.3), (National Institute of Standards and Technology, Gaithersburg, MD, 2005).
17. D. W. Lbbers, The meaning of tissue oxygen distribution curves and its measurement by means of platinum electrodes., Progress in Respiratory Research, (S. Karger, New York, 1969), Vol. 3, p. 12.
18. W. R. Ott, A physical explanation of the lognormality of pollutant concentrations., J. Air Waste Manage. Assoc. 40 (10), 1378-1383 (1990). (Pubitemid 20354700)
19. P. V. Neti and R. W. Howell, Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals., J. Nucl. Med. 47 (6), 1049-1058 (2006). (Pubitemid 46939959)
20. G. A. Kaltsas, D. Papadogias, P. Makras, and A. B. Grossman, Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues., Endocr. Relat Cancer 12 (4), 683-699 (2005). 10.1677/erc.1.01116 (Pubitemid 41815771)
21. S. J. Goldsmith, Radioimmunotherapy of lymphoma: Bexxar and Zevalin., Semin. Nucl. Med. 40 (2), 122-135 (2010). 10.1053/j.semnuclmed.2009.11.002
22. H. Ahmadzadehfar, H. J. Biersack, and S. Ezziddin, Radioembolization of liver tumors with yttrium-90 microspheres., Semin. Nucl. Med. 40 (2), 105-121 (2010). 10.1053/j.semnuclmed.2009.11.001
23. F. Winkler, S. V. Kozin, R. T. Tong, S. S. Chae, M. F. Booth, I. Garkavtsev, L. Xu, D. J. Hicklin, D. Fukumura, E. di Tomaso, L. L. Munn, and R. K. Jain, Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases., Cancer Cells 6 (6), 553-563 (2004). (Pubitemid 40017699)